Cost effectiveness of pegylated interferon alpha 2b and ribavirin combination in chronic hepatitis C

Documenti analoghi

• The effect of pegylated interferon-alpha2b and ribavirin combination therapy for chronic hepatitis C infection in elderly patients
  di: Nishikawa, Hiroki, et al.
  Pubblicazione: (2012)
• Pharmacokinetics of ribavirin in combined interferon-alpha 2b and ribavirin therapy for chronic hepatitis C virus infection
  di: Tsubota, Akihito, et al.
  Pubblicazione: (2003)
• Prediction of Effect of Pegylated Interferon Alpha-2b plus Ribavirin Combination Therapy in Patients with Chronic Hepatitis C Infection
  di: Takayama, Tetsuro, et al.
  Pubblicazione: (2011)
• Thyroid disturbances in children treated with combined pegylated interferon-alpha and ribavirin for chronic hepatitis C
  di: Rashed, Yasser K., et al.
  Pubblicazione: (2020)
• Thymosin Alpha-1 in Combination with Pegylated Interferon and Ribavirin in Chronic Hepatitis C Patients Who have Failed to Prior Pegylated Interferon and Ribavirin Treatment
  di: Baek, Yang Hyun, et al.
  Pubblicazione: (2007)